Skip to main content
Premium Trial:

Request an Annual Quote

Proteome Sciences, Sigma-Aldrich Reach Deal to Sell ProteoPrep Products

Premium

Proteome Sciences this week entered into a non-exclusive licensing deal allowing Sigma-Aldrich to continue selling products under the ProteoPrep name in Europe, Japan, and Australia.

Sigma-Aldrich has been selling immunodepletion kits under ProteoPrep name, which is a trademark registered to Proteome Sciences in the three geographies covered by this week's announcement.

Currently, Sigma-Aldrich sells 11 ProteoPrep kits. The license includes those products and all future products containing chemicals and reagents for disrupting cells, tissues, or other biological material, and the extraction of biological molecules such as proteins, lipids, and carbohydrates.

The deal also covers methods and processes related to assays for diagnosing disease, as well as chemical markers for determining proteins and peptides by disruption of cells, tissues, and other biological materials, and for targeting drugs.

Proteome Sciences received a signing fee and will receive royalties on product sales. Other financial terms of the deal were not disclosed.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.